Dosage unit comprising a prostaglandin analog for treating constipation
DC
First Claim
Patent Images
1. A method for relieving constipation in a human patient in need of relief of constipation that comprises administering to the patient a dosage unit comprising (i) 24 μ
- g+/−
10% of a PG analog represented by Formula (I) and/or its tautomer and (ii) a pharmaceutically suitable excipient;
7 Assignments
Litigations
0 Petitions
Accused Products
Abstract
A dosage unit for treating constipation in a human patient is described. The dosage unit of the invention comprises a halogenated prostaglandin analog and a pharmaceutically suitable excipient. The dosage unit relieves constipation without substantial side effects.
18 Citations
7 Claims
-
1. A method for relieving constipation in a human patient in need of relief of constipation that comprises administering to the patient a dosage unit comprising (i) 24 μ
- g+/−
10% of a PG analog represented by Formula (I) and/or its tautomer and (ii) a pharmaceutically suitable excipient;
- View Dependent Claims (2, 3, 4, 5, 6, 7)
- g+/−
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
-
Current AssigneeSucampo AG (Mallinckrodt plc)
-
Original AssigneeSucampo AG (Mallinckrodt plc)
-
InventorsUeno, Ryuji, Patchen, Myra L.
-
Primary Examiner(s)Padmanabhan, Sreeni
-
Assistant Examiner(s)HUANG, GIGI GEORGIANA
-
Application NumberUS10/293,516Publication NumberTime in Patent Office3,351 DaysField of Search514/456, 514/460, 514/892, 514/211, 514/573US Class Current514/573CPC Class CodesA61K 31/557 Eicosanoids, e.g. leukotrie...A61P 1/00 Drugs for disorders of the ...A61P 1/10 LaxativesA61P 1/14 Prodigestives, e.g. acids, ...A61P 43/00 Drugs for specific purposes...C07C 53/23 containing ringsC07D 311/94 condensed with rings other ...
